Risk factors for Kaposi's Sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA

James J. Goedert, Manhattan Charurat, William A. Blattner, Ronald C. Hershow, Jane Pitt, Clemente Diaz, Lynne M. Mofenson, Karen Green, Howard Minkoff, Mary E. Paul, David L Thomas, Denise Whitby

Research output: Contribution to journalArticle

Abstract

Objectives: We sought to identify risk factors for infection with the Kaposi's Sarcoma-associated herpesvirus (KSHV) among pregnant women and to examine a reported association of KSHV with injecting drug use (IDU) and hepatitis C virus (HCV) infection. Design: Cross-sectional evaluation of questionnaire data and KSHV and HCV seroprevalence in the Women and Infants Transmission Study. Methods: In sera collected from HIV-1-infected pregnant women (n = 887) and, at age 12 months, their offspring (n = 900) at six sites in the USA and Puerto Rico, KSHV and HCV antibodies were detected with sensitive and specific enzyme immunoassays. Risk of KSHV was estimated by the unadjusted and adjusted odds ratio (ORadj) and 95% confidence interval (CI). The geographic referent sites were Chicago and Boston. Results: Forty-seven (5.3%) of the women and three (0.3%) of the infants were KSHV seropositive. In univariate and multivariate analyses, KSHV in the women was associated with enrollment in Puerto Rico, Houston or Brooklyn (ORadj, 4.3; 95% CI, 1.8-10.4) or Manhattan (ORadj, 9.8; 95% CI, 3.7-25.6); non-completion of high school (ORadj, 1.8; 95% CI, 0.9-3.4); the number of sexually transmitted diseases (ORadj, 1.4; 95% CI, 1.0-1.9 per disease); and especially with IDU and HCV infection (ORadj, 3.5; 95% CI, 1.5-7.9). Conclusions: Transmission of KSHV by blood inoculation may be highly inefficient, but our data support the hypothesis that it does occur. Large formal studies to evaluate whether KSHV transmission occurs via transfusion are needed to inform decisions regarding screening volunteer blood donors to protect the blood supply.

Original languageEnglish (US)
Pages (from-to)425-433
Number of pages9
JournalAIDS
Volume17
Issue number3
DOIs
StatePublished - Feb 14 2003

Fingerprint

Herpesviridae Infections
Human Herpesvirus 8
HIV-1
Pregnant Women
Confidence Intervals
Hepacivirus
Puerto Rico
Virus Diseases
Hepatitis C Antibodies
Seroepidemiologic Studies
Sexually Transmitted Diseases
Blood Donors
Immunoenzyme Techniques
Pharmaceutical Preparations
Volunteers
Multivariate Analysis
Odds Ratio

Keywords

  • Drug users
  • Hepatitis
  • Herpesvirus
  • Heterosexual transmission
  • Kaposi's sarcoma
  • Risk factors
  • Seroprevalence

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Goedert, J. J., Charurat, M., Blattner, W. A., Hershow, R. C., Pitt, J., Diaz, C., ... Whitby, D. (2003). Risk factors for Kaposi's Sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS, 17(3), 425-433. https://doi.org/10.1097/00002030-200302140-00017

Risk factors for Kaposi's Sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. / Goedert, James J.; Charurat, Manhattan; Blattner, William A.; Hershow, Ronald C.; Pitt, Jane; Diaz, Clemente; Mofenson, Lynne M.; Green, Karen; Minkoff, Howard; Paul, Mary E.; Thomas, David L; Whitby, Denise.

In: AIDS, Vol. 17, No. 3, 14.02.2003, p. 425-433.

Research output: Contribution to journalArticle

Goedert, JJ, Charurat, M, Blattner, WA, Hershow, RC, Pitt, J, Diaz, C, Mofenson, LM, Green, K, Minkoff, H, Paul, ME, Thomas, DL & Whitby, D 2003, 'Risk factors for Kaposi's Sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA', AIDS, vol. 17, no. 3, pp. 425-433. https://doi.org/10.1097/00002030-200302140-00017
Goedert, James J. ; Charurat, Manhattan ; Blattner, William A. ; Hershow, Ronald C. ; Pitt, Jane ; Diaz, Clemente ; Mofenson, Lynne M. ; Green, Karen ; Minkoff, Howard ; Paul, Mary E. ; Thomas, David L ; Whitby, Denise. / Risk factors for Kaposi's Sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. In: AIDS. 2003 ; Vol. 17, No. 3. pp. 425-433.
@article{f62083501a764d2ca9636c3ad997eaed,
title = "Risk factors for Kaposi's Sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA",
abstract = "Objectives: We sought to identify risk factors for infection with the Kaposi's Sarcoma-associated herpesvirus (KSHV) among pregnant women and to examine a reported association of KSHV with injecting drug use (IDU) and hepatitis C virus (HCV) infection. Design: Cross-sectional evaluation of questionnaire data and KSHV and HCV seroprevalence in the Women and Infants Transmission Study. Methods: In sera collected from HIV-1-infected pregnant women (n = 887) and, at age 12 months, their offspring (n = 900) at six sites in the USA and Puerto Rico, KSHV and HCV antibodies were detected with sensitive and specific enzyme immunoassays. Risk of KSHV was estimated by the unadjusted and adjusted odds ratio (ORadj) and 95{\%} confidence interval (CI). The geographic referent sites were Chicago and Boston. Results: Forty-seven (5.3{\%}) of the women and three (0.3{\%}) of the infants were KSHV seropositive. In univariate and multivariate analyses, KSHV in the women was associated with enrollment in Puerto Rico, Houston or Brooklyn (ORadj, 4.3; 95{\%} CI, 1.8-10.4) or Manhattan (ORadj, 9.8; 95{\%} CI, 3.7-25.6); non-completion of high school (ORadj, 1.8; 95{\%} CI, 0.9-3.4); the number of sexually transmitted diseases (ORadj, 1.4; 95{\%} CI, 1.0-1.9 per disease); and especially with IDU and HCV infection (ORadj, 3.5; 95{\%} CI, 1.5-7.9). Conclusions: Transmission of KSHV by blood inoculation may be highly inefficient, but our data support the hypothesis that it does occur. Large formal studies to evaluate whether KSHV transmission occurs via transfusion are needed to inform decisions regarding screening volunteer blood donors to protect the blood supply.",
keywords = "Drug users, Hepatitis, Herpesvirus, Heterosexual transmission, Kaposi's sarcoma, Risk factors, Seroprevalence",
author = "Goedert, {James J.} and Manhattan Charurat and Blattner, {William A.} and Hershow, {Ronald C.} and Jane Pitt and Clemente Diaz and Mofenson, {Lynne M.} and Karen Green and Howard Minkoff and Paul, {Mary E.} and Thomas, {David L} and Denise Whitby",
year = "2003",
month = "2",
day = "14",
doi = "10.1097/00002030-200302140-00017",
language = "English (US)",
volume = "17",
pages = "425--433",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Risk factors for Kaposi's Sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA

AU - Goedert, James J.

AU - Charurat, Manhattan

AU - Blattner, William A.

AU - Hershow, Ronald C.

AU - Pitt, Jane

AU - Diaz, Clemente

AU - Mofenson, Lynne M.

AU - Green, Karen

AU - Minkoff, Howard

AU - Paul, Mary E.

AU - Thomas, David L

AU - Whitby, Denise

PY - 2003/2/14

Y1 - 2003/2/14

N2 - Objectives: We sought to identify risk factors for infection with the Kaposi's Sarcoma-associated herpesvirus (KSHV) among pregnant women and to examine a reported association of KSHV with injecting drug use (IDU) and hepatitis C virus (HCV) infection. Design: Cross-sectional evaluation of questionnaire data and KSHV and HCV seroprevalence in the Women and Infants Transmission Study. Methods: In sera collected from HIV-1-infected pregnant women (n = 887) and, at age 12 months, their offspring (n = 900) at six sites in the USA and Puerto Rico, KSHV and HCV antibodies were detected with sensitive and specific enzyme immunoassays. Risk of KSHV was estimated by the unadjusted and adjusted odds ratio (ORadj) and 95% confidence interval (CI). The geographic referent sites were Chicago and Boston. Results: Forty-seven (5.3%) of the women and three (0.3%) of the infants were KSHV seropositive. In univariate and multivariate analyses, KSHV in the women was associated with enrollment in Puerto Rico, Houston or Brooklyn (ORadj, 4.3; 95% CI, 1.8-10.4) or Manhattan (ORadj, 9.8; 95% CI, 3.7-25.6); non-completion of high school (ORadj, 1.8; 95% CI, 0.9-3.4); the number of sexually transmitted diseases (ORadj, 1.4; 95% CI, 1.0-1.9 per disease); and especially with IDU and HCV infection (ORadj, 3.5; 95% CI, 1.5-7.9). Conclusions: Transmission of KSHV by blood inoculation may be highly inefficient, but our data support the hypothesis that it does occur. Large formal studies to evaluate whether KSHV transmission occurs via transfusion are needed to inform decisions regarding screening volunteer blood donors to protect the blood supply.

AB - Objectives: We sought to identify risk factors for infection with the Kaposi's Sarcoma-associated herpesvirus (KSHV) among pregnant women and to examine a reported association of KSHV with injecting drug use (IDU) and hepatitis C virus (HCV) infection. Design: Cross-sectional evaluation of questionnaire data and KSHV and HCV seroprevalence in the Women and Infants Transmission Study. Methods: In sera collected from HIV-1-infected pregnant women (n = 887) and, at age 12 months, their offspring (n = 900) at six sites in the USA and Puerto Rico, KSHV and HCV antibodies were detected with sensitive and specific enzyme immunoassays. Risk of KSHV was estimated by the unadjusted and adjusted odds ratio (ORadj) and 95% confidence interval (CI). The geographic referent sites were Chicago and Boston. Results: Forty-seven (5.3%) of the women and three (0.3%) of the infants were KSHV seropositive. In univariate and multivariate analyses, KSHV in the women was associated with enrollment in Puerto Rico, Houston or Brooklyn (ORadj, 4.3; 95% CI, 1.8-10.4) or Manhattan (ORadj, 9.8; 95% CI, 3.7-25.6); non-completion of high school (ORadj, 1.8; 95% CI, 0.9-3.4); the number of sexually transmitted diseases (ORadj, 1.4; 95% CI, 1.0-1.9 per disease); and especially with IDU and HCV infection (ORadj, 3.5; 95% CI, 1.5-7.9). Conclusions: Transmission of KSHV by blood inoculation may be highly inefficient, but our data support the hypothesis that it does occur. Large formal studies to evaluate whether KSHV transmission occurs via transfusion are needed to inform decisions regarding screening volunteer blood donors to protect the blood supply.

KW - Drug users

KW - Hepatitis

KW - Herpesvirus

KW - Heterosexual transmission

KW - Kaposi's sarcoma

KW - Risk factors

KW - Seroprevalence

UR - http://www.scopus.com/inward/record.url?scp=0037436235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037436235&partnerID=8YFLogxK

U2 - 10.1097/00002030-200302140-00017

DO - 10.1097/00002030-200302140-00017

M3 - Article

VL - 17

SP - 425

EP - 433

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 3

ER -